West Pharmaceutical $WST took a brutal 38% hit in one day after investors learned the company’s golden goose its SmartDose line was dragging profits, not boosting them. In this episode of Bulls and Betrayal: Holding Wall Street Accountable, we unpack how upbeat earnings calls masked a structural downturn and shrinking contracts, sparking a major securities class action. Perfect for biotech investors, analysts, and market skeptics. Expect sharp insights, legal context, and straight talk. We’re not lawyers or accountants, so don’t take this as legal or financial advice.Explore more at ZLK.com.